- Home
- ORIC vs KBDC Comparison
ORIC vs KBDC Comparison
Compare ORIC & KBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORIC | KBDC |
|---|---|---|
| Founded | 2014 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 861.3M | 980.7M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ORIC | KBDC |
|---|---|---|
| Price | $7.60 | $14.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $19.73 | $15.50 |
| AVG Volume (30 Days) | ★ 1.5M | 201.9K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 13.16% |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $193.84 |
| Revenue Next Year | N/A | $9.00 |
| P/E Ratio | ★ N/A | $33.79 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.23 | $13.06 |
| 52 Week High | $14.93 | $16.28 |
Technical Indicators
Market Signals| Indicator | ORIC | KBDC |
|---|---|---|
| Relative Strength Index (RSI) | 37.14 | 43.85 |
| Support Level | N/A | $14.02 |
| Resistance Level | $13.89 | $14.70 |
| Average True Range (ATR) | 0.51 | 0.29 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 18.46 | 20.00 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About KBDC Kayne Anderson BDC Inc.
Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company, investing mainly in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation mainly through debt investments in middle-market companies.